Age group |
20–49 |
50–64 |
<60 |
60–69 |
70–79 |
80–89 |
90+ |
|
Transmission probability per contact during pre-symptomatic stage |
0.0438 |
(Public Health Ontario, 2020) |
Calibrated to incidence data for LTCFs in Ontario |
Incubation period (days) |
Log-Normal(shape: 1.434, scale: 0.661) |
(Lauer et al., 2020) |
Asymptomatic period (days) |
Gamma(shape: 5, scale: 1) |
Derived from (Gatto et al., 2020; He et al., 2020) |
Pre-symptomatic period (days) |
Gamma(shape: 1.058, scale: 2.174) |
(He et al., 2020) |
Infectious period from onset of symptoms (days) |
Gamma(shape: 2.768, scale: 1.1563) |
Derived from (Li et al., 2020a) |
Proportion of individuals with comorbidities |
0.18 |
0.38 |
1 |
(Adams et al., 2020; Ontario Long Term Care Association, 2019) |
Proportion of infected individuals developing asymptomatic infection |
0.328 |
0.328 |
0.328 |
0.258 |
0.188 |
0.188 |
0.188 |
(Mizumoto et al., 2020) |
Proportion of symptomatic cases developing severe illness |
0.15 |
0.40 |
0.8 |
(Moghadas et al., 2020b) |
Hospitalization rate of symptomatic cases |
23.5% |
23.5% |
18.2% |
15.1% |
13.4% |
9.3% |
7.1% |
(Public Health Ontario, 2020) |
Case fatality rate |
0.21% |
0.21% |
8.4% |
18.8% |
24.1% |
27.9% |
35.4% |
(Public Health Ontario, 2020) |
Length of hospital stay |
Gamma(shape: 4.5, scale: 2.75) |
(Sanche et al., 2020) |